FDA Adverse Event Death Summary report: N

SPRINT FIDELIS

MDR report key: 3053507 · Received April 11, 2013

Report

Report Number
2649622-2013-04936
Event Type
Death
Date Received
April 11, 2013
Date of Event
March 13, 2013
Report Date
March 13, 2013
Manufacturer
MPRI
Product Code
LWS
PMA / PMN Number
P920015
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE INFORMATION SUBMITTED REFLECTS ALL RELEVANT DATA RECEIVED. IF ADDITIONAL RELEVANT INFORMATION IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED. CONCOMITANT PRODUCT: 5076 IMPLANTABLE PACING LEAD (B)(6) 2006. (B)(4). THE LEAD WAS NOT RETURNED TO THE MANUFACTURER AND WILL NOT BE EVALUATED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING THE EXPLANT OF THE RIGHT VENTRICULAR (RV) LEAD DUE TO OVERSENSING, THE SUPERIOR VENA CAVA WAS TORN. THEPATIENT SUBSEQUENTLY DIED THE DAY AFTER THE EXPLANT PROCEDURE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156108 SPRINT FIDELIS DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER LWS MPRI 694958

Patients

Seq Age Sex Outcome Treatment
1 00066 YR Death| H| L| R D154AWG IMPLANTABLE CARDIOVERTER DEFIBRILLATOR